RPGLIFE₹2,780.00

RPG Life Sciences Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersGUFICBIOGUJTHEMUNICHEMLABORCHPHARMASMSPHARMAFDCIOLCPINDSWFTLABMcap ₹4,597 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Revenue from Operations——707.5
Other Income——25.6
Total Income——733.1
Expenses
+ Cost of Materials Consumed——136.0
+ Purchases of Stock-in-Trade——138.1
+ Changes in Inventories——-22.0
+ Employee Benefit Expense——141.5
+ Finance Costs——0.9
+ Depreciation & Amortisation——21.5
+ Other Expenses——166.9
Total Expenses——582.8
EBITDA——147.1
EBIT——125.6
Profit
PBT before Exceptional Items——150.3
+ Exceptional Items——3.9
Pretax Income——154.2
+ Current Tax——34.8
+ Deferred Tax——4.3
Tax Expense——39.0
Net Income——115.2
+ Net Income — Continuing Ops——115.2
+ Other Comprehensive Income——-0.6
Total Comprehensive Income——114.5
Per Share
Basic EPS——18.08
Diluted EPS——69.64
Other Comprehensive Income — detail
+ Other Comprehensive Income——-0.6
+ Items NOT to be Reclassified to P&L——-0.9
+ Tax on Items NOT to be Reclassified——-0.2
Per Share — as-filed variants
Basic EPS — Continuing Operations——18.08
Diluted EPS — Discontinued Operations——69.64
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit——455.4
Gross Margin %——64.37
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)——150.3
− Exceptional Items (reconciliation)——3.9
Net Income Adj (tax-effected)——112.3
EPS Adj——17.62
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value——8.00
Paid Up Equity Capital——13.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.